Oxford BioDynamics Plc (LON:OBD – Get Free Report)’s share price shot up 39% during trading on Wednesday . The stock traded as high as GBX 0.70 ($0.01) and last traded at GBX 0.70 ($0.01). 95,053,336 shares traded hands during mid-day trading, an increase of 900% from the average session volume of 9,501,976 shares. The stock had previously closed at GBX 0.50 ($0.01).
Oxford BioDynamics Stock Up 19.4 %
The firm’s 50-day moving average price is GBX 1.05 and its two-hundred day moving average price is GBX 3.02. The company has a debt-to-equity ratio of 370.22, a quick ratio of 2.80 and a current ratio of 0.68. The firm has a market cap of £1.86 million, a PE ratio of -9.95 and a beta of 0.42.
About Oxford BioDynamics
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Read More
- Five stocks we like better than Oxford BioDynamics
- Canadian Penny Stocks: Can They Make You Rich?
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Find and Profitably Trade Stocks at 52-Week Lows
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
